Clonidine Dosing for Opioid Withdrawal
For adults with moderate to severe opioid withdrawal (COWS >8) without cardiovascular contraindications, clonidine should be dosed at 0.1-0.3 mg orally, with the ability to repeat dosing as needed based on symptom severity and blood pressure tolerance, though buprenorphine remains the superior first-line treatment when available. 1
Critical Context: Clonidine is Second-Line Treatment
- Buprenorphine is significantly more effective than clonidine for managing opioid withdrawal, with patients more likely to complete treatment (NNT=4), experience less severe withdrawal symptoms, and stay in treatment longer 1
- Clonidine should be reserved for situations where opioid agonist therapy (buprenorphine or methadone) is unavailable, contraindicated, or refused by the patient 1
- α2-adrenergic agonists like clonidine are appropriate for symptomatic treatment in non-hypotensive patients with opioid withdrawal 1
Specific Clonidine Dosing Protocol
Initial Dose
- Start with 0.1-0.3 mg orally for symptomatic opioid withdrawal 1
- A recent randomized trial used 0.3 mg oral clonidine as the standard dose, though this resulted in 63% of patients requiring rescue medication within 1 hour 2
Dose Titration and Monitoring
- Dosing must be closely supervised due to varying individual sensitivity to clonidine's sedative, hypotensive, and withdrawal-suppressing effects 3
- Monitor blood pressure before each dose, as hypotension is the primary dose-limiting adverse effect 2, 4
- Repeat dosing can be given based on withdrawal symptom severity (use COWS score) and blood pressure tolerance 1
Duration Considerations
- The duration of action of clonidine is shorter than many opioids, particularly long-acting formulations like methadone 3
- Multiple daily doses are typically required for adequate symptom control 3
Assessment of Withdrawal Severity
- Use the Clinical Opiate Withdrawal Scale (COWS) to objectively assess severity 1
- COWS scoring: 5-12 = mild; 13-24 = moderate; 25-36 = moderately severe; >36 = severe 1
- Clonidine is most appropriate for moderate to severe withdrawal (COWS >8) 1
Critical Safety Warnings
Hypotension Risk
- Hypotension is the most common adverse effect limiting clonidine use 2, 4
- Check blood pressure before each dose and hold if systolic BP <90 mmHg or symptomatic hypotension develops 1
- Lofexidine (an alternative α2-agonist) causes less hypotension than clonidine but is less widely available 4
Clonidine Withdrawal Syndrome
- Never abruptly discontinue clonidine once a patient is established on it, as this can cause severe rebound hypertension and potential hypertensive crisis 5, 6
- Clonidine withdrawal syndrome occurs in at least 1.2% of patients and is influenced by treatment duration and daily dosage 6
- If discontinuing clonidine, taper the dose slowly to avoid rebound hypertension 5, 6
Adjunctive Symptomatic Treatments
Clonidine addresses primarily the adrenergic symptoms of withdrawal but should be combined with other symptomatic treatments 1:
- Antiemetics (e.g., promethazine) for nausea and vomiting 1
- Benzodiazepines for anxiety, muscle cramps, and to reduce catecholamine release 1
- Loperamide for diarrhea 1
Common Pitfalls to Avoid
- Do not use clonidine as first-line when buprenorphine is available - the evidence clearly shows buprenorphine's superiority 1
- Do not give clonidine to hypotensive patients - this is explicitly contraindicated 1
- Do not use fixed dosing schedules - individual sensitivity varies widely and requires symptom-based and blood pressure-based titration 3
- Do not discharge patients on clonidine without clear instructions about the risks of abrupt discontinuation and the need for gradual tapering 5, 6
- Do not rely on clonidine alone for long-term treatment - it is best suited as transitional treatment, ideally toward naltrexone induction or connection to opioid use disorder treatment programs 3